NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS)
$0 None (None%)
Analysed NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS) News Sources
ASX Penny Stocks To Consider In December 2025
12-12-2025
yahoo.com
HEALEY ALS Platform Trial Regimen I expands to 240 participants
27-05-2026
yahoo.com
Neurizon passes halfway mark in HEALEY ALS trial as NUZ-001 dosing accelerates
12-06-2026
proactiveinvestors.com
HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
17-07-2026
yahoo.com
What is the current price of NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS)?
The current price of NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS) is $0.
NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS) since the previous trading day is $None.
NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS)?
The most recent average sentiment score for NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS) is 86 out of 100.
What is the most recent average sentiment for NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS)?
The most recent sentiment for NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS) is .
SEC-8K** Filing Available For NEURIZON THERAPEUTICS LTD (NUZTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.